AAAAAA

   
Results: 1-8 |
Results: 8
EFFECT OF ALENDRONATE ADDED TO ONGOING HORMONE REPLACEMENT THERAPY INTHE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
Authors: LINDSAY R COSMAN F CARY DJ LISS CL REAGAN J BYRNES CA MELTON ME PETTY KJ
Citation: R. Lindsay et al., EFFECT OF ALENDRONATE ADDED TO ONGOING HORMONE REPLACEMENT THERAPY INTHE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, Arthritis and rheumatism, 41(9), 1998, pp. 575-575
COMBINED ANALYSIS OF 2 MULTICENTER STUDIES OF FINASTERIDE 5 MG IN THETREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
Authors: BYRNES CA LISS CL TENOVER JL LIPPERT MC GILLENWATER JY
Citation: Ca. Byrnes et al., COMBINED ANALYSIS OF 2 MULTICENTER STUDIES OF FINASTERIDE 5 MG IN THETREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 26-31
EFFICACY AND TOLERABILITY OF FINASTERIDE IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA - A PRIMARY-CARE STUDY
Authors: TENOVER JL PAGANO FA MORTON AS LISS CL BYRNES CA
Citation: Jl. Tenover et al., EFFICACY AND TOLERABILITY OF FINASTERIDE IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA - A PRIMARY-CARE STUDY, Clinical therapeutics, 19(2), 1997, pp. 243-258
COMPARISON OF HIGH VERSUS LOW-DOSE ENALAPRIL THERAPY ON CLINICAL OUTCOMES AND NEUROENDOCRINE ACTIVATION IN ADVANCED HEART-FAILURE
Authors: FOWLER MB VAGELOS RH SCHROEDER JS BENEDICT CR WILLSON K BOUCHER M MULLIN A PRIKAZSKY LM LISS CL LABELLE P
Citation: Mb. Fowler et al., COMPARISON OF HIGH VERSUS LOW-DOSE ENALAPRIL THERAPY ON CLINICAL OUTCOMES AND NEUROENDOCRINE ACTIVATION IN ADVANCED HEART-FAILURE, Circulation, 96(8), 1997, pp. 105-105
EFFECTS OF FINASTERIDE ON HEALTH-RELATED QUALITY-OF-LIFE IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
Authors: GIRMAN CJ KOLMAN C LISS CL BOLOGNESE JA BINKOWITZ BS STONER E
Citation: Cj. Girman et al., EFFECTS OF FINASTERIDE ON HEALTH-RELATED QUALITY-OF-LIFE IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA, The Prostate, 29(2), 1996, pp. 83-90
COMPARISON OF THE EFFECTS ON QUALITY-OF-LIFE AND OF THE EFFICACY AND TOLERABILITY OF LOVASTATIN VERSUS PRAVASTATIN
Authors: WEIR MR BERGER ML WEEKS ML LISS CL SANTANELLO NC
Citation: Mr. Weir et al., COMPARISON OF THE EFFECTS ON QUALITY-OF-LIFE AND OF THE EFFICACY AND TOLERABILITY OF LOVASTATIN VERSUS PRAVASTATIN, The American journal of cardiology, 77(7), 1996, pp. 475-479
EFFICACY, TOLERABILITY, AND EFFECT ON HEALTH-RELATED QUALITY-OF-LIFE OF FINASTERIDE VERSUS PLACEBO IN MEN WITH SYMPTOMATIC BENIGN PROSTATICHYPERPLASIA - A COMMUNITY-BASED STUDY
Authors: BYRNES CA MORTON AS LISS CL LIPPERT MC GILLENWATER JY
Citation: Ca. Byrnes et al., EFFICACY, TOLERABILITY, AND EFFECT ON HEALTH-RELATED QUALITY-OF-LIFE OF FINASTERIDE VERSUS PLACEBO IN MEN WITH SYMPTOMATIC BENIGN PROSTATICHYPERPLASIA - A COMMUNITY-BASED STUDY, Clinical therapeutics, 17(5), 1995, pp. 956-969
THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX - DOES MODE OF ADMINISTRATION AFFECT ITS PSYCHOMETRIC PROPERTIES
Authors: BARRY MJ FOWLER FJ CHANG YC LISS CL WILSON H STEK M
Citation: Mj. Barry et al., THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX - DOES MODE OF ADMINISTRATION AFFECT ITS PSYCHOMETRIC PROPERTIES, The Journal of urology, 154(3), 1995, pp. 1056-1059
Risultati: 1-8 |